Editorial: Antibiotics for disease.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000453:epidemiology*; D001900:Boston; D003023:Cloxacillin / Q000627:therapeutic use; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D007710:Klebsiella Infections / Q000453:epidemiology / Q000382:microbiology; D010403:Penicillin Resistance; D011552:Pseudomonas Infections / Q000453:epidemiology / Q000382:microbiology; D018805:Sepsis / Q000453:epidemiology* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology; D019966:Substance-Related Disorders / Q000517:prevention & control; D014481:United States
D000900:Anti-Bacterial Agents; D000667:Ampicillin; D003023:Cloxacillin